1 | Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists. 2023;66:890 doi: 10.1021/acs.jmedchem.2c01768 |
2 | A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models. 2022;10:e004592 doi: 10.1136/jitc-2022-004592 |
3 | Therapeutic Potentials of A2B Adenosine Receptor Ligands: Current Status and Perspectives. 2019;25:2741 doi: 10.2174/1381612825666190717105834 |
4 | Characteristics and the role of purinergic receptors in pathophysiology with focus on immune response. 2020;39:97 doi: 10.1080/08830185.2020.1723582 |